Artículos por temáticas

Neuropsychiatric symptoms of dementia: are pharmacological treatments effective and safe?

Ford AH.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):4. doi: 10.1136/jnnp-2014-308420. Epub 2014 May 29.

Naming ability in patients with mild to moderate Alzheimer's disease: what changes occur with the evolution of the disease?

Silagi ML, Bertolucci PH, Ortiz KZ.

Clinics (Sao Paulo). 2015 Jun;70(6):423-8. doi: 10.6061/clinics/2015(06)07. Epub 2015 Jun 1.

Epoch-based Entropy for Early Screening of Alzheimer's Disease

Houmani N, Dreyfus G, Vialatte FB.

Int J Neural Syst. 2015 Dec;25(8):1550032. doi: 10.1142/S012906571550032X. Epub 2015 Aug 21.

Alcohol consumption and mortality in patients with mild Alzheimer's disease: a prospective cohort study

Berntsen S, Kragstrup J, Siersma V, Waldemar G, Waldorff FB.

BMJ Open. 2015 Dec 11;5(12):e007851. doi: 10.1136/bmjopen-2015-007851.

Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans

Saykin AJ, Shen L, Yao X, Kim S, Nho K, Risacher SL, Ramanan VK, Foroud TM, Faber KM, Sarwar N, Munsie LM, Hu X, Soares HD, Potkin SG, Thompson PM, Kauwe JS, Kaddurah-Daouk R, Green RC, Toga AW, Weine

Alzheimers Dement. 2015 Jul;11(7):792-814. doi: 10.1016/j.jalz.2015.05.009.

Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer's disease: a systematic review and meta-analysis

Hsu WY, Ku Y, Zanto TP, Gazzaley A.

Neurobiol Aging. 2015 Aug;36(8):2348-59. doi: 10.1016/j.neurobiolaging.2015.04.016. Epub 2015 May 1.

Nutritional status according to the stages of Alzheimer's disease

Marino LV, Ramos LF, Chiarello PG.

Aging Clin Exp Res. 2015 Aug;27(4):507-13. doi: 10.1007/s40520-014-0302-3. Epub 2014 Dec 25.

Cognitive intervention therapy as treatment for behaviour disorders in Alzheimer disease: evidence on efficacy and neurobiological correlations

García-Alberca JM.

Neurologia. 2015 Jan-Feb;30(1):8-15. doi: 10.1016/j.nrl.2012.10.002. Epub 2012 Dec 15.

18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease

Bailly M, Ribeiro MJ, Vercouillie J, Hommet C, Gissot V, Camus V, Guilloteau D.

Clin Nucl Med. 2015 Feb;40(2):e111-6. doi: 10.1097/RLU.0000000000000666.

The effectiveness of reality orientation in the treatment of Alzheimer's disease

Camargo CH, Justus FF, Retzlaff G.

Am J Alzheimers Dis Other Demen. 2015 Aug;30(5):527-32. doi: 10.1177/1533317514568004. Epub 2015 Jan 14.

Is Alzheimer disease related to age-related macular degeneration?

Seden D, Alime G, Kadir D, Serpil D, Levent T, Özlem T.

Turk J Med Sci. 2015;45(5):1115-21. doi: 10.3906/sag-1406-135.

Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's disease

Schmidt C, Gerlach N, Peter C, Gherib K, Lange K, Friede T, Zerr I.

J Alzheimers Dis. 2015;43(4):1229-36. doi: 10.3233/JAD-141581.

Systematic review of strengths and limitations of randomized controlled trials for non-pharmacological interventions in mild cognitive impairment: focus on Alzheimer's disease

Horr T, Messinger-Rapport B, Pillai JA.

J Nutr Health Aging. 2015 Feb;19(2):141-53. doi: 10.1007/s12603-014-0565-6.

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

Chouraki V, Beiser A, Younkin L, Preis SR, Weinstein G, Hansson O, Skoog I, Lambert JC, Au R, Launer L, Wolf PA, Younkin S, Seshadri S.

Alzheimers Dement. 2015 Mar;11(3):249-57.e1. doi: 10.1016/j.jalz.2014.07.001. Epub 2014 Sep 10.

Phenotypical variation in Alzheimer's disease: insights from posterior cortical atrophy

Slattery CF, Crutch SJ, Schott JM.

Pract Neurol. 2015 Feb;15(1):2-4. doi: 10.1136/practneurol-2014-000955. Epub 2014 Sep 19.